p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status [31] MDM2 and MDM4 are negative regulators of TP53 activity, targeting degradation via ubiquitination. The gene discussed is MDM4; the disease is acute myeloid leukemia.